Introduction
Immusante is a phytopharmaceutical formulation, recommended as an immunotherapeutic support in immunocompromised conditions such as viral infections, opportunistic infections, and chemotherapy and radiotherapy-induced neutropenia. Immusante augments immune function, attenuates disease manifestation, and improves resistance to diseases.
Composition
Each Immusante tablet contains: Exts. Shanta (Prosopis glandulosa) 150 mg Lodhra (Symplocos racemosa) 100 mg
Location: United States, Massachusetts, Cambridge
Member count: 11-50
Total raised: $72M
Founded date: 2010
Investors 2
| Date | Name | Website |
| - | T1D Fund | t1dfund.or... |
| 17.07.2021 | ARCH Ventu... | archventur... |
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 14.11.2017 | Series C | $40M | ARCH Ventu... | vcnewsdail... |
| 22.12.2014 | Series B | $12M | - | vcnewsdail... |
| 13.12.2011 | Series A | $20M | - | vcnewsdail... |
Mentions in press and media 14
| Date | Title | Description | Category | Author | Source |
| 12.09.2018 | Term Sheet... | REBOOT REPRESENTATION Good mo... | - | - | fortune.co... |
| 11.09.2018 | ImmusanT R... | ImmusanT, Inc., a Cambridge, M... | USA | - | finsmes.co... |
| 14.11.2017 | ImmusanT L... | CAMBRIDGE, MA, ImmusanT, a c... | - | - | vcnewsdail... |
| 14.11.2017 | ImmusanT R... | CAMBRIDGE, Mass.--(BUSINESS WI... | - | - | citybizlis... |
| 14.11.2017 | ImmusanT R... | ImmusanT, Inc., a Cambridge, M... | USA | - | finsmes.co... |
| 22.12.2014 | Helping th... | The company said its adjuvant-... | - | - | medcitynew... |
| 22.12.2014 | ImmusanT R... | CAMBRIDGE, MA, ImmusanT Inc.... | - | - | vcnewsdail... |
| 22.12.2014 | ImmusanT R... | ImmusanT Inc., a Cambridge, Ma... | USA | - | finsmes.co... |
| 05.09.2012 | Celiac dis... | In these patients, the body’s ... | - | - | medcitynew... |
| 14.12.2011 | ImmusanT R... | ImmusanT, Inc., a Cambridge, M... | funding U... | - | finsmes.co... |
Show more